BSG and rectal neoplasm: In this work, we investigated if the expression of CD147, as well as the mutational status of residual tumor rectal samples, could be associated with the rectal tumor recurrence after neoadjuvant chemoradiotherapy and curative surgery and thus could be used as a biomarker for LR risk stratification.